FDA says Novo's obesity pill TV Ad is false or misleading
Reuters
Feb 09
FDA says Novo's obesity pill TV Ad is false or misleading
Feb 9 (Reuters) - The Food and Drug Administration said a television advertisement for Novo Nordisk's NOVOb.CO weight loss pill is "false or misleading", according to a letter dated February 5.
(Reporting by Sriparna Roy in Bengaluru; Editing by Vijay Kishore)
((Sriparna.Roy@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.